Implantable Bluetooth Pacemaker Streamlines Remote Monitoring
|
By HospiMedica International staff writers Posted on 24 Jan 2022 |

Image: The Alizea pacemaker with Bluetooth connectivity (Photo courtesy of MicroPort CRM)
A novel pacemaker that pairs to a home monitor provides timely automated alerts and patient triggered warnings when symptomatic.
The MicroPort CRM (Clamart, France) Alizea Bluetooth Pacemaker is cardiac rhythm management (CRM) device with two sensors (an accelerometer and a minute ventilation sensor) that adapt the physiologic response to suit patient activity. The two sensors continually cross-check each other, preventing unnecessary rate increases due to artifacts. Features include SafeR, an AV node management solution that reduces ventricular pacing while managing long PR intervals; SAM, a sleep apnea monitoring tool; and AutoMRI mode, which detects an MRI field and automatically switches to asynchronous mode.
Alizea connects via Bluetooth to SmartView Connect, a home remote monitoring system that offers patient monitoring and follow-up, timely alerts and detailed reports on the patient, removing the need for hospital-based routine examinations and reducing burden on the healthcare system. It also offers customizable alerts, including alerts that oversee system integrity, ensuring the pacemaker’s continuous function; alerts that indicate potential dislodgement or lead fracture; and notifications of post-MRI device function.
“We successfully launched Alizea in Europe in June 2021, and Japan is the second region to benefit from its advanced technological functions,” said Benoît Clinchamps, President of MicroPort CRM, on the occasion of regulatory approval of the Alizea in Japan. “As part of our commitment to improve the lives of as many patients as possible, and to support healthcare professionals in their mission, we will continue to deploy Alizea and Smartview Connect around the world.”
“Around 64,000 patients are implanted with a pacemaker each year in Japan, and coupled with the difficulties that have arisen from the current health crisis, there is a growing need to monitor patients remotely, without them having to travel,” said Noboru Shimizu, VP of MicroPort CRM sales in Japan. “Thanks to Alizea pacemakers and its SmartView Connect monitor, we are positioning ourselves in the Japanese market with the very best in cardiac pacing. I am convinced that this will allow us to strengthen our presence in Japan.”
Within the right atrium of the heart is a natural pacemaker that sends an electrical stimulus that travels from the pacemaker (the SA node) to the ventricles (the AV node). In the presence of an AV block, the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed.
Related Links:
MicroPort
The MicroPort CRM (Clamart, France) Alizea Bluetooth Pacemaker is cardiac rhythm management (CRM) device with two sensors (an accelerometer and a minute ventilation sensor) that adapt the physiologic response to suit patient activity. The two sensors continually cross-check each other, preventing unnecessary rate increases due to artifacts. Features include SafeR, an AV node management solution that reduces ventricular pacing while managing long PR intervals; SAM, a sleep apnea monitoring tool; and AutoMRI mode, which detects an MRI field and automatically switches to asynchronous mode.
Alizea connects via Bluetooth to SmartView Connect, a home remote monitoring system that offers patient monitoring and follow-up, timely alerts and detailed reports on the patient, removing the need for hospital-based routine examinations and reducing burden on the healthcare system. It also offers customizable alerts, including alerts that oversee system integrity, ensuring the pacemaker’s continuous function; alerts that indicate potential dislodgement or lead fracture; and notifications of post-MRI device function.
“We successfully launched Alizea in Europe in June 2021, and Japan is the second region to benefit from its advanced technological functions,” said Benoît Clinchamps, President of MicroPort CRM, on the occasion of regulatory approval of the Alizea in Japan. “As part of our commitment to improve the lives of as many patients as possible, and to support healthcare professionals in their mission, we will continue to deploy Alizea and Smartview Connect around the world.”
“Around 64,000 patients are implanted with a pacemaker each year in Japan, and coupled with the difficulties that have arisen from the current health crisis, there is a growing need to monitor patients remotely, without them having to travel,” said Noboru Shimizu, VP of MicroPort CRM sales in Japan. “Thanks to Alizea pacemakers and its SmartView Connect monitor, we are positioning ourselves in the Japanese market with the very best in cardiac pacing. I am convinced that this will allow us to strengthen our presence in Japan.”
Within the right atrium of the heart is a natural pacemaker that sends an electrical stimulus that travels from the pacemaker (the SA node) to the ventricles (the AV node). In the presence of an AV block, the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed.
Related Links:
MicroPort
Latest Critical Care News
- Nanogel Technology Almost 100% Effective in Destroying Drug-Resistant Bacteria Within Hours
- Wearable Ultrasound Sensor Delivers Noninvasive Treatment Without Surgery
- Gel-Free ECG System to Transform Heart Health Diagnosis
- Biodegradable Patch Repairs Damaged Tissue After Heart Attack
- Magnetically Guided Microrobots to Enable Targeted Drug Delivery

- Smart Nanomaterials Detect and Treat Traumatic Brain Injuries Simultaneously
- Earlier Blood Transfusion Could Reduce Heart Failure and Arrhythmia in Heart Disease Patients
- 'Smart' Shirt Detects Epileptic Seizures in Real Time
- Skin Patch Measures Effectiveness of Flu/COVID Vaccines in 10 Minutes
- Complete Revascularization Reduces Risk of Death from Cardiovascular Causes
- Tiny Fish-Inspired Robots Navigate Through Body to Deliver Targeted Drug Therapy
- Coronary Artery Stenosis Could Protect Patients from Pulmonary Embolism Effects
- Sweat-Powered Sticker Turns Drinking Cup into Health Sensor
- Skin-Mounted 3D Microfluidic Device Analyzes Sweat for Real-Time Health Assessment
- New Therapeutic Brain Implants to Eliminate Need for Surgery
- Stem Cell Patch Gently Heals Damaged Hearts Without Open-Heart Surgery
Channels
Surgical Techniques
view channelNovel Endoscopy Technique Provides Access to Deep Lung Tumors
Detecting lung cancer early can save lives, but diagnosing small tumors deep in the outer regions of the lungs remains a major clinical challenge. Although CT scans frequently identify tiny suspicious... Read more
New Study Findings Could Halve Number of Stent Procedures
When a coronary artery becomes acutely blocked during a heart attack, opening it immediately is essential to prevent irreversible damage. However, many patients also have other narrowed vessels that appear... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







